Ever Supreme Bio Technology , Ltd Common Stock

Ever Supreme Bio Technology , Ltd (6712.TWO) currently reports a common stock of $1B as of June 2026. That compares with $880M in the prior-year period — up 16.2% year over year. Use the charts on this page to explore Ever Supreme Bio Technology , Ltd's common stock history and peer comparisons.

Ever Supreme Bio Technology , Ltd's common stock increased from $880M to $1B — a 16.2% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ever Supreme Bio Technology , Ltd reported $1B in common stock as of June 2026. That compares with $880M in the prior-year period — up 16.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $1B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Ever Supreme Bio Technology , Ltd, and consider following 6712.TWO for alerts when major investors trade the stock.

Ever Supreme Bio Technology , Ltd is classified in the Healthcare sector. On common stock, it currently shows $1B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 6712.TWO with unrelated industries.